HE4 as a biomarker for ovarian and endometrial cancer management

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

(2009) K Huhtinen et al.   BRITISH JOURNAL OF CANCER

Body mass index and risk of ovarian cancer

(2009) Michael F. Leitzmann et al.   CANCER

Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Postmenopausal Women at High-Risk for Ovarian Cancer

(2008) K. A. Lowe et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Use of Yeast-Secreted In vivo Biotinylated Recombinant Antibodies (Biobodies) in Bead-Based ELISA

(2008) N. Scholler et al.   CLINICAL CANCER RESEARCH

Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence

(2008) Laura J. Havrilesky et al.   GYNECOLOGIC ONCOLOGY

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

(2007) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY